Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are predicting strong growth driven by the continued success of Lilly's blockbuster medications, particularly its insulin portfolio. How